INS and metabolic syndrome: In a metabolomics study including 5181 participants from the cross-sectional Metabolic Syndrome in Men study, the levels of KYNA and other downstream metabolites weakened insulin secretion and insulin sensitivity but enhanced susceptibility to T2DM [75].